XML 87 R10.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES | 3 Months Ended
--- | ---
Mar. 31, 2024
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES |
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES | NOTE 4 - INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES On August 9, 2023, the Company and Insigma, Inc., a Virginia corporation ("Insigma"), and a wholly owned subsidiary of Futuris Company, a Wyoming corporation (“FTRS”), entered into an asset purchase agreement where Recruiter Consulting agreed to sell its right, title, and exclusive interest in certain client contracts and associated staff, contractors, business information, and relationships related thereto to Insigma. As consideration for the Acquired Assets, and upon completion of the assignment of certain Acquired Assets to Insigma, Insigma shall issue to Recruiter Consulting a number of shares of common stock of FTRS equal to $500,000 based on the 30-day Volume Weighted Average Price (VWAP) preceding the Closing Date (see Note 6). The deal was finalized on October 2, 2023, when Management Solutions, LLC approved the transfer to Futuris, and on October 5, 2023, the Company received a total of 9,518,605 FTRS Company common stock. As of the closing date of October 2, 2023, the share price of Futuris common stock was $0.0579 per share. As such, the fair value of the transaction consideration received on the closing date was $551,127. During the year ended December 31, 2023, the Company received 2,000 shares initially valued at $17,000 in exchange for $150,000 of accounts receivable which was fully reserved for. The Company’s investments in marketable equity securities are being held for an indefinite period and thus have been classified as available for sale. Cost basis of securities held as of both March 31, 2024, and December 31, 2023, is $552,527, while accumulated unrealized losses were $278,895 and $170,383 as of March 31, 2024, and December 31, 2023, respectively. The fair market value of available for sale marketable securities were $273,632 and $382,144 as of March 31, 2024, and December 31, 2023, respectively. The reconciliation of the investment in marketable securities is as follows for the three months ended March 31, 2024, and 2023:
|  | March 31, 2024 |  |  | March 31, 2023 |
Beginning Balance – January 1 |  | $ | 382,144 |  |  | $ | - |
Additions |  |  | - |  |  |  | - |
Recognized losses |  |  | (108,512 | ) |  |  | - |
Ending Balance – March 31 |  | $ | 273,632 |  |  | $ | - |
Net losses on equity investments were as follows:
|  | Three Months Ended |
|  | March 31, |
|  | 2024 |  |  | 2023 |
Net realized losses on investment sold or assigned |  | $ | - |  |  | $ | - |
Net unrealized losses on investments still held |  |  | 108,512 |  |  |  | - |
Total |  | $ | 108,512 |  |  | $ | - |

X
- References No definition available. + Details
Name: | rcrt_InvestmentInMarketableSecuritiesDisclosureTextBlock
Namespace Prefix: | rcrt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration